Clarify the Role of Paxlovid or Molnupiravir for COVID-19

New oral antivirals will raise questions about treating COVID-19.

Recommend Paxlovid (nirmatrelvir/ritonavir) first-line for most outpatients with mild to moderate COVID-19, since it seems more effective...and molnupiravir when other options aren't available.

Eligibility. Educate that these meds are for patients with a positive COVID-19 test who are at high risk of developing severe illness (age 65 or older, diabetes, etc)...regardless of vaccination status.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote